These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19050602)

  • 1. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
    Keegan SP; Gallagher EM; Ernst NE; Young EJ; Mueller EW
    Ann Pharmacother; 2009 Jan; 43(1):19-27. PubMed ID: 19116377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of argatroban: experiences in continuous renal replacement therapy in critically ill patients after cardiac surgery.
    Klingele M; Bomberg H; Lerner-Gräber A; Fliser D; Poppleton A; Schäfers HJ; Groesdonk HV
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1918-24. PubMed ID: 24485959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
    Kim SC; Tran N; Schewe JC; Boehm O; Wittmann M; Graeff I; Hoeft A; Baumgarten G
    J Cardiothorac Surg; 2015 Feb; 10():19. PubMed ID: 25879883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.
    Begelman SM; Baghdasarian SB; Singh IM; Militello MA; Hursting MJ; Bartholomew JR
    J Intensive Care Med; 2008; 23(5):313-20. PubMed ID: 18701526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.
    Williamson DR; Boulanger I; Tardif M; Albert M; Grégoire G
    Pharmacotherapy; 2004 Mar; 24(3):409-14. PubMed ID: 15040656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
    Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
    Ansara AJ; Arif S; Warhurst RD
    Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM; McCollum DA; Hursting MJ
    J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.
    Reichert MG; MacGregor DA; Kincaid EH; Dolinski SY
    Ann Pharmacother; 2003 May; 37(5):652-4. PubMed ID: 12708939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
    Tang IY; Cox DS; Patel K; Reddy BV; Nahlik L; Trevino S; Murray PT
    Ann Pharmacother; 2005 Feb; 39(2):231-6. PubMed ID: 15632219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
    du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
    Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
    Matthai WH; Hursting MJ; Lewis BE; Kelton JG
    Thromb Res; 2005; 116(2):121-6. PubMed ID: 15907526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.
    Ferreira JA; Johnson DW
    Ren Fail; 2015 Aug; 37(7):1232-6. PubMed ID: 26108135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.